The Oxford team erroneously claimed that dexamethasone was the first medication to improve the survival of seriously ill Covid-19 patients. Other treatments also show promise.
Dexamethasone Reduces Mortality In Seriously Ill Covid-19 Patients—And So Do Other Treatments
